Electroceuticals Market / Bioelectric Medicine Market Worth $33.6 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222053956 Download an Illustrative overview:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222053956 Browse in-depth TOC on "Electroceuticals Market / Bioelectric Medicine Market" 457 - Tables 46 - Figures 400 - Pages Electroceuticals Market / Bioelectric Medicine Market Scope:   The cardiac pacemakers & implantable cardioverter defibrillators segment...

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222053956

Browse in-depth TOC on "Electroceuticals Market / Bioelectric Medicine Market"

457 - Tables
46 - Figures
400 - Pages

Electroceuticals Market / Bioelectric Medicine Market Scope:

 

The cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share of the electroceuticals market, by product segment, in 2022

Based on product, the electroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, neuromodulators, cochlear implants, and retinal implants. The cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share of the electroceuticals market in 2022, primarily due to the increasing prevalence of cardiovascular disorders worldwide. Additionally, the rising incidence of sudden cardiac arrests, a growing elderly population, and advancements in product development are anticipated to drive market growth.

Non-invasive electroceutical devices segment to register the highest growth rate during the forecast period

The electroceuticals market is divided into two segments: implantable electroceutical devices and non-invasive electroceutical devices. In 2022, the noninvasive electroceutical devices segment experienced the highest growth rate. This growth is attributed to factors such as increased R&D investments by companies for novel product development and technological advancements in this segment.

Arrhythmia segment accounted for the largest share of the electroceuticals market, by product segment, in 2022

Based on application, the electroceuticals market is segmented into arrhythmia, chronic pain management, Parkinson's disease, urine incontinence, depression, epilepsy, and others. In 2022, the arrhythmia segment emerged as the dominant force in the overall market. This dominance is fueled by the rising prevalence of arrhythmia, a condition often managed with implantable cardioverter-defibrillators and cardiac pacemakers.

North America is the largest regional market for electroceuticals market

The global electroceuticals market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, North America held the largest market share in the electroceuticals market in 2022. A significant share in North America can be attributed to the presence of major medical device manufacturers like Abbott and Boston Scientific Corporation. The region's well-established healthcare system and access to advanced products have further propelled market growth. Following North America, Europe secured the second position, fueled by the increasing demand for innovative medical devices for treatment. The region's robust healthcare infrastructure and the presence of major bioelectric medicine manufacturers are expected to continue driving market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=222053956

Electroceuticals Market / Bioelectric Medicine Market Dynamics:

Drivers:

Restraints:

Opportunities:

Challenge:

Key Market Players of Electroceuticals Market / Bioelectric Medicine Industry:

The major players in this market are Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), LivaNova PLC (UK), Cochlear Ltd. (Australia), MicroPort Scientific Corporation (China), Sonova Group (Switzerland), Nevro Corp. (US), Axonics Modulation Technologies, Inc. (US), Neuronetics, Inc. (US), ElectroCore, Inc. (US), NeuroPace, Inc. (US), BIOTRONIK (Germany), Medico S.p.A. (Italy), Nurotron Biotechnology Co. Ltd. (US), MED-EL (Austria), Aleva Neurotherapeutics SA (Switzerland), NeuroSigma, Inc. (US), BioWave Corporation (US), Soterix Medical Inc. (US), Bioinduction (Amber Therapeutics) (UK), GiMer Medical (Taiwan), Cefaly (Belgium), BioControl Medical (Israel), and tVNS Technologies GmbH (Germany).

The primary interviews conducted for this report can be categorized as follows:

Recent Developments of Electroceuticals Market / Bioelectric Medicine Industry:

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=222053956

Electroceuticals Market / Bioelectric Medicine Market - Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall electroceuticals market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.  

The report provides insights on the following pointers:

Related Reports:

Orthopedic Braces & Supports Market - Global Forecasts to 2029

Regenerative Medicine Market - Global Forecasts to 2028

Home Healthcare Market - Global Forecasts to 2028

Bone Cement & Glue Market - Global Forecasts to 2028

Cold Pain Therapy Market - Global Forecasts to 2027

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/electroceutical-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/electroceutical.asp

Logo: https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg

 

 

View original content:https://www.prnewswire.co.uk/news-releases/electroceuticals-market--bioelectric-medicine-market-worth-33-6-billion--marketsandmarkets-302087752.html